IDDF2019-ABS-0075 Serum Metabonomic Analysis and Establishment of Diagnostic Model of Pancreatic Cancer Associated Diabetes

Xiangyi He,Yaozong Yuan

DOI: https://doi.org/10.1136/gutjnl-2019-iddfabstracts.137

2019-01-01

Abstract:Background For the lack of effective screening tool on new-onset diabetic mellitus for pancreatic cancer (PC), the current study aimed to establish a diagnostic model based on serum metabolomics to discriminate pancreatic cancer (PC) from new onset diabetic mellitus. Methods Serum samples from patients with new-onset diabetic mellitus (n = 30) and new onset diabetic mellitus with PC (N=30) were examined by liquid chromatography-mass spectrometry (LC-MS). Data were analyzed using orthogonal projection to latent structures (OPLS) and t-test for the differentially expressed metabolites between two groups. The diagnostic model was established using Logistic regression via a stepwise method on the first 15 new onset diabetic mellitus and new onset diabetic mellitus with PC training set. It was then evaluated in the late 15 new onset diabetic mellitus and new onset diabetic mellitus with PC testing set. Results Five metabolites identified in positive ion model were 3-ketosphingosine, Arachidonoyl dopamine, PE(18:2), Ubiquinone-1 and Valine. C16 Sphingosine-1-phosphate, keto palmitic acid, Isoleucine, N-Succinyl-L-diaminopimelic acid and Uridine in negative ion model were identified to be differentially expressed in the two groups. The regression model established in training set was p=e(Xβ)/(1+e(Xβ)), (Xβ) = -158.975 - 1.891 (Age) + 0.309 (PE18:2) + 1.035 (C16_Sphingosine_1_phosphate) + 0.084 (Isoleucine) + 1.1145 ( N_Succinyl_L_diaminopimelic_acid). The AUC of this model was 0.982 in testing set; the sensitivity and specificity were both 93.3%. (table 1). Conclusions Serum metabolomics-based diagnostic approach is a promising method for screening PC from new onset diabetic mellitus.